Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 30, 2014Biology of Blood and Marrow TransplantationOpen Access

Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLuciano J. CostaUniversity of Alabama at BirminghamJHJiaxing HuangJiangxi University of Traditional Chinese MedicinePHParameswaran HariMedical College of Wisconsin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Costa et al. (2014) studied this question.

synapsesocial.com/papers/6a12971bc031bb6829a6eec4https://doi.org/10.1016/j.bbmt.2014.12.024
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma1996 · 2,581 citations
  2. 2Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio‐geo‐demographic factors in the era of novel agents2014 · 80 citations
  3. 3Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma2009 · 65 citations
  4. 4Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis2008 · 127 citations